Corvus Pharmaceuticals Inc (CRVS)
1.73
+0.12
(+7.45%)
USD |
NASDAQ |
May 02, 16:00
1.72
-0.01
(-0.58%)
Pre-Market: 20:00
Corvus Pharmaceuticals Price to Book Value: 2.193 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 2.193 |
| May 01, 2024 | 2.041 |
| April 30, 2024 | 1.965 |
| April 29, 2024 | 2.003 |
| April 26, 2024 | 1.838 |
| April 25, 2024 | 1.876 |
| April 24, 2024 | 1.914 |
| April 23, 2024 | 1.940 |
| April 22, 2024 | 1.825 |
| April 19, 2024 | 1.775 |
| April 18, 2024 | 1.787 |
| April 17, 2024 | 1.724 |
| April 16, 2024 | 1.864 |
| April 15, 2024 | 1.864 |
| April 12, 2024 | 1.940 |
| April 11, 2024 | 1.978 |
| April 10, 2024 | 1.914 |
| April 09, 2024 | 2.066 |
| April 08, 2024 | 2.168 |
| April 05, 2024 | 2.218 |
| April 04, 2024 | 2.142 |
| April 03, 2024 | 2.218 |
| April 02, 2024 | 2.358 |
| April 01, 2024 | 2.358 |
| March 28, 2024 | 2.256 |
| Date | Value |
|---|---|
| March 27, 2024 | 2.269 |
| March 26, 2024 | 2.231 |
| March 25, 2024 | 2.231 |
| March 22, 2024 | 2.269 |
| March 21, 2024 | 2.332 |
| March 20, 2024 | 2.345 |
| March 19, 2024 | 2.485 |
| March 18, 2024 | 2.409 |
| March 15, 2024 | 2.409 |
| March 14, 2024 | 2.383 |
| March 13, 2024 | 2.535 |
| March 12, 2024 | 2.561 |
| March 11, 2024 | 2.548 |
| March 08, 2024 | 2.688 |
| March 07, 2024 | 2.890 |
| March 06, 2024 | 2.726 |
| March 05, 2024 | 2.675 |
| March 04, 2024 | 2.738 |
| March 01, 2024 | 2.764 |
| February 29, 2024 | 2.840 |
| February 28, 2024 | 2.916 |
| February 27, 2024 | 2.992 |
| February 26, 2024 | 2.916 |
| February 23, 2024 | 2.979 |
| February 22, 2024 | 2.928 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4096
Minimum
Sep 27 2022
3.754
Maximum
Sep 21 2021
1.469
Average
1.284
Median
Oct 23 2023
Price to Book Value Benchmarks
| Cyclacel Pharmaceuticals Inc | 5.386 |
| Arbutus Biopharma Corp | 4.555 |
| Oragenics Inc | 2.987 |
| Relmada Therapeutics Inc | 1.315 |
| MAIA Biotechnology Inc | 135.77 |
Price to Book Value Related Metrics
| Price | 1.73 |
| Earnings Yield | -32.37% |
| Market Cap | 84.84M |